The researchers at the Dana-Farber Cancer Institute in Boston reported that the cancer drug Gleevec had compelled metastatic melanoma into decline for the first time.
The case involves a 79-year-old woman with malignant cells tumors in some parts of her abdomen. The tumor cells conceded an irregularity in a gene called KIT, so the patient was […]
